Journal of Diabetes and Its Complications
Volume 24, Issue 4 , Pages 242-249 , July 2010

Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes

  • Patricia Alvarez-Muñoz

      Affiliations

    • Department of Physiology and Pharmacology, University of Salamanca, Spain
    • ,
  • Michael Mauer

      Affiliations

    • Department of Medicine, University of Minnesota, MN, USA
    • Department of Pediatrics, University of Minnesota, MN, USA
    • ,
  • Youngki Kim

      Affiliations

    • Department of Pediatrics, University of Minnesota, MN, USA
    • ,
  • Stephen S. Rich

      Affiliations

    • Department of Public Health Sciences, University of Virginia, VA, USA
    • ,
  • Michael E. Miller

      Affiliations

    • Department of Biostatistical Sciences, Wake Forest University School of Medicine, NC, USA
    • ,
  • Gregory B. Russell

      Affiliations

    • Department of Biostatistical Sciences, Wake Forest University School of Medicine, NC, USA
    • ,
  • José M. Lopez-Novoa

      Affiliations

    • Department of Physiology and Pharmacology, University of Salamanca, Spain
    • ,
  • M. Luiza Caramori

      Affiliations

    • Department of Medicine, University of Minnesota, MN, USA
    • Department of Pediatrics, University of Minnesota, MN, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 612 624 5150; fax: +1 612 626 3133.

Received 17 June 2008 ,Revised 5 February 2009 ,Accepted 20 March 2009.

References 

  1. Affymetrix Microarray Suite User's Guide Version 5.0 . In: Affymetrix Microarray Suite User's Guide, Version 5.0. 2001;p. 412–415Santa Clara, CA
  2. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. American Journal of Human Genetics. 1998;62(5):1198–1211
  3. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. Journal of Biological Chemistry. 1999;274(2):584–594
  4. Border WA, Noble N. Cytokines in kidney disease: the role of transforming growth factor beta. American Journal of Kidney Disease. 1993;22(1):105–113
  5. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. Journal of Clinical Investigation. 1992;90(1):1–7
  6. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normo-albuminuric Type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036–1040
  7. Caramori ML, Kim Y, Fioretto P, Huang C, Rich SS, Miller ME, et al. Cellular basis of diabetic nephropathy: IV. Antioxidant enzyme mRNA expression levels in skin fibroblasts of Type 1 diabetic sibling pairs. Nephrology and Dialysis Transplantation. 2006;21(11):3122–3126
  8. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing diabetes. Diabetes. 2002;51(2):506–513
  9. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, et al. Defective intracellular antioxidant enzyme production in Type 1 diabetic patients with nephropathy. Diabetes. 2000;49(12):2170–2177
  10. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massagué J, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. Journal of Biological Chemistry. 1992;267(27):19027–19030
  11. Diez-Marques L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa JM, Lamas S, et al. Expression of endoglin in human mesangial cells: Modulation of extracellular matrix synthesis. Biochimica et Biophysica Acta. 2002;1587(1):36–44
  12. Ellis EN, Steffes MW, Goetz FC, Sutherland DER, Mauer SM. Glomerular filtration surface in type I diabetes mellitus. Kidney International. 1986;29(4):889–894
  13. Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS. Assessment of 115 candidate genes for diabetic nephropathy by transmission/dis-equilibrium test. Diabetes. 2005;54(11):3305–3318
  14. Fioretto P, Steffes MW, B osa J, Rich SS, Miller ME, Mauer M. Is diabetic nephropathy inherited? Studies of glomerular structure in Type 1 diabetic sibling pairs. Diabetes. 1999;48(4):865–869
  15. Fioretto P, Steffes MW, Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes. 1994;43(11):1358–1364
  16. Guerrero-Esteo M, Lastres P, Letamendia A, Perez-Alvarez MJ, Langa C, Lopez LA, et al. Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. European Journal of Cell Biology. 1999;78(9):614–623
  17. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. Journal of Biological Chemistry. 2002;277(32):29197–29209
  18. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75(4):800–803
  19. Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, et al. Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in Type 1 diabetic patients. Diabetologia. 2004;47(10):1789–1794
  20. Huang C, Kim Y, Caramori ML, Moore JH, Rich SS, Mychaleckyj JC, et al. Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes. 2006;55(6):1826–1831
  21. Huang C, Kim Y, Caramori MLA, Fish AJ, Rich SS, Miller ME, et al. Cellular basis of diabetic nephropathy II. The TGF-system and diabetic nephropathy lesions in Type 1 diabetes. Diabetes. 2002;51(12):3577–3581
  22. Iori E, Marescotti MC, Vedovato M, Ceolotto G, Avogaro A, Tiengo A, et al. In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy. Diabetologia. 2003;46(4):524–530
  23. Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney International. 1999;55(4):1582–1596
  24. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, et al. Endoglin modulates cellular responses to TGF-beta 1. Journal of Cell Biology. 1996;133(5):1109–11021
  25. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, Valasco B, et al. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. Journal of Biological Chemistry. 1998;273(49):33011–33019
  26. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England Journal of Medicine. 2006;355(10):992–1005
  27. Li D, Chen H, Mehta JL. Angiotensin II via activation of Type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Hypertension. 2001;38(5):1062–1067
  28. Llorca O, Trujillo A, Blanco FJ, Bernabeu C. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. Journal of Molecular Biology. 2007;65(3):694–705
  29. Luque A, Cabanas C, Raab U, Letamendia A, Paez E, Herreros L, et al. The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglin. FEBS Letters. 1997;413(2):265–268
  30. Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D. Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter. Kidney International. 1996;50(5):1684–1693
  31. Massagué J. TGF-beta signal transduction. Annual Review of Biochemistry. 1998;67:753–791
  32. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia Type 1. Nature Genetics. 1994;8(4):345–351
  33. McKnight AJ, Maxwell AP, Sawcer S, Compston A, Setakis E, Patterson CC, et al. A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. Journal of the American Society of Nephrology. 2006;17(3):831–836
  34. Obreo J, Diez-Marques L, Lamas S, Duwell A, Eleno N, Bernabeu C, et al. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts. Cellular Physiology and Biochemistry. 2004;14(4-6):301–310
  35. Osterholm AM, He B, Pitkaniemi J, Albinsson L, Berg T, Sarti C, et al. Genome-wide scan for Type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney International. 2007;71(2):140–145
  36. Pérez-Gómez E, Eleno N, López-Novoa JM, Ramirez JR, Velasco B, Letarte M, et al. Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene. 2005;24(27):4450–4461
  37. Prieto M, Rodriguez-Pena A, Arevalo M, Rivas JV, Duwel A, Eleno N, et al. Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction. Kidney Blood Pressure Research. 2005;28(1):32–40
  38. Prieto M, Rodríguez-Peña AB, Düwel A, Rivas JV, Docherty N, Perez-Barriocanal F, et al. Temporal changes in renal endoglin and TGF-beta 1 expression following ureteral obstruction in rats. Journal of Physiological Biochemistry. 2005;6(3):457–467
  39. Rich SS. Genetics of diabetes and its complications. Journal of the American Society of Nephrology. 2006;17(2):353–360
  40. Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney International. 1992;41(3):557–559
  41. Rodriguez-B ero A, Obreo J, Alvarez-Munoz P, Pandiella A, Bernabeu C, Lopez-Novoa JM. Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/MAPK activation. Cellular Physiology and Biochemistry. 2006;18(1-3):135–142
  42. Rodriguez-B ero A, Obreo J, Eleno N, Rodriguez A, Bernabeu C, Lopez-Novoa JM. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta 1. Biochemical and Biophysical Research Communications. 2001;282(1):142–147
  43. Rodriguez-Peña A, Eleno N, Duwell A, Arevalo M, Perez-Barriocanal F, Flores O, et al. Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension. 2002;40(5):713–720
  44. Rodriguez-Peña A, Prieto M, Duwel A, Rivas JV, Eleno N, Perez-Barriocanal F, et al. Up-regulation of endoglin, a TGF-beta-binding protein in rats with experimental renal fibrosis induced by renal mass reduction. Nephrology and Dialysis Transplantation. 2001;16(Suppl 1):34–39
  45. Roy-Chaudhury P, Simpson JG, Power DA. Endoglin, a transforming growth factor-beta-binding protein, is upregulated in chronic progressive renal disease. Experimenal Nephrology. 1997;5(1):55–60
  46. Schnaper HW, Hayashida T, Poncelet AC. It's a Smad world: regulation of TGF-beta signaling in the kidney. Journal of the American Society of Nephrology. 2002;13(4):1126–1128
  47. Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. American Journal of Physiology. 1994;267(6 Pt 2):F1094–F1101
  48. Siczkowski M, Davies JE, Sweeney FP, Kofoed-Enevoldsen A, Ng LL. Na+/H+ exchanger isoform-1 abundance in skin fibroblasts of type I diabetic patients with nephropathy. Metabolism. 1995;44(6):791–795
  49. Tessari P, Puricelli L, Iori E, Arrigoni G, Vedovato M, James P, et al. Altered chaperone and protein turnover regulators expression in cultured skin fibroblasts from Type 1 diabetes mellitus with nephropathy. Journal of Proteome Research. 2007;6(3):976–986
  50. Torbjörnsdotter TB, Perrin NE, Jaremko GA, Berg UB. Widening of foot processes in normoalbuminuric adolescents with Type 1 diabetes. Pediatric Nephrology. 2005;20(6):750–758
  51. Trevisan R, Fioretto P, B osa J, Mauer M. Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney International. 1999;55(6):2383–2389
  52. Trevisan R, Yip J, Sarika L, Li LK, Viberti G. Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. Journal of the American Society of Nephrology. 1997;8(7):1133–1139
  53. Velasco S, Alvarez-Muñoz P, Pericacho M, Dijke PT, Bernabéu C, López-Novoa JM, et al. l- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. Journal of Cell Science. 2008;121(Pt 6):913–919
  54. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine. 2006;12(6):642–649
  55. Zhu Y, Usui HK, Sharma K. Regulation of transforming growth factor beta in diabetic nephropathy: Implications for treatment. Seminars in Nephrology. 2007;27(2):153–160

PII: S1056-8727(09)00032-4

doi: 10.1016/j.jdiacomp.2009.03.004

Journal of Diabetes and Its Complications
Volume 24, Issue 4 , Pages 242-249 , July 2010

Article Tools

* Image Usage & Resolution